IXC invex therapeutics ltd
Add to My Watchlist 4.76% ! 11.0¢

News: IXC Invex Therapeutics Says Got HREC And TGA Approval To Commence Phase 3 In Australia

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    04/07/22
    11:35
    Post #: 62354749

    July 4 (Reuters) - Invex Therapeutics Ltd (IXC) :

    • HREC AND TGA APPROVAL TO COMMENCE PHASE 3 IN AUSTRALIA-IXC.AX
    • GOT HUMAN RESEARCH ETHICS COMMITTEE NOD & CLINICAL TRIAL NOTIFICATION SCHEME CLEARANCE BY TGA
    • APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL IN AUSTRALIA
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Explore the latest ASX Market News
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
NEWS Southern Silver Exploration: Unlocking value at Cerro Las Minitas amid rising metal prices
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS High-grade silver intercepts confirmed at Kempfield Project
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
11.0¢ 		Change
0.005(4.76%) 		Mkt cap ! $8.266M
Open High Low Value Volume
11.0¢ 11.0¢ 11.0¢ $4.95K 45K

Buyers (Bids)

No. Vol. Price($)
1 3500 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 25000 1
View Market Depth
Last trade - 10.56am 19/09/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.